RxDoctor Payments DataLook up a doctor →

Danilo Corales

Internal Medicine · Lexington, KYNPI 1013951771

Payments from drug & device makers

$17,129in general payments, 2019–2025

Across 1,134 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • Pfizer$1K
  • GSK$1K
  • Lilly USA, LLC$926
  • AstraZeneca$742
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk166$2,337
AbbVie(2 entities)162$2,227
Pfizer121$1,418
GSK68$1,063
Lilly USA, LLC64$926
AstraZeneca(2 entities)45$742
Astellas Pharma US Inc35$698
Amgen41$687
Takeda Pharmaceuticals U.S.A., Inc.54$660
Boehringer Ingelheim45$653
Johnson & Johnson40$558
Otsuka America Pharmaceutical, Inc.25$462
Abbott15$373
Novartis22$369
Sanofi-aventis U.S. LLC23$356
Biohaven Pharmaceuticals, Inc.10$280
Supernus Pharmaceuticals, Inc.20$280
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$251
Axsome Therapeutics, Inc.7$234
Biohaven Pharmaceutical Holding Company Ltd.18$214
Phathom Pharmaceuticals, Inc.13$207
Corcept Therapeutics7$189
Bayer12$184
Sumitomo Pharma America, Inc.10$183
Merck9$124
Vanda Pharmaceuticals Inc.4$95
Esperion Therapeutics, Inc.6$90
Amarin Pharma, Inc.6$89
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$81
Arbor Pharmaceuticals, Inc.5$75
Eisai Inc.5$75
Azurity Pharmaceuticals, Inc.4$66
Lundbeck LLC4$60
Exact Sciences4$59
Ironwood Pharmaceuticals, Inc4$52
Dexcom, Inc.1$51
Harmony Biosciences LLC2$50
Almatica Pharma LLC2$46
Neurocrine Biosciences, Inc.3$46
Xeris Pharmaceuticals, Inc.2$44
Ardelyx, Inc.2$44
Boston Scientific2$42
Currax Pharmaceuticals LLC3$38
Insulet Corporation2$33
Alnylam Pharmaceuticals Inc.2$31
Nevro Corp.1$28
Corium, LLC2$27
Teva Pharmaceuticals USA, Inc.2$27
Shield Therapeutics Inc1$24
Abiomed1$23
Dynavax Technologies Corporation1$19
Tonix Medicines, Inc.1$18
Vivus LLC1$16
Scilex Pharmaceuticals Inc.1$15
QOL Medical, LLC1$15
Amneal Pharmaceuticals LLC1$14
Verona Pharma, Inc.1$14
Kowa Pharmaceuticals America, Inc.1$14
Antares Pharma, Inc.1$13
E.r. Squibb & Sons, L.L.C.1$11

How this compares

$17,129 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky →

Medicare billing

Part B allowed, 2024
$244,241
Medicare patients
606
Services billed
2,975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Lexington

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →